The Atlantic, GSK launch community health program at WHYY
The Atlantic magazine, with drugmaker GlaxoSmithKline as a sponsor, last week launched the first of several panel discussions that it is calling "A Conversation on Community Health."
The Atlantic, GSK launch community health program at WHYY
David Sell
The Atlantic magazine, with drugmaker GlaxoSmithKline as a sponsor, last week launched the first of several panel discussions that it is calling "A Conversation on Community Health."
The first panel and town hall meeting was held at WHYY in Philadelphia.
Philadelphia's Bill Cosby was the most famous panelist, but The Atlantic's Vice President Elizabeth Baker Keffer and GSK's North America Pharmaceuticals President Deirdre Connelly welcomed panelists and the audience.
Besides Cosby, the town hall speakers included Dr. Alvin Poussaint, professor of psychiatry at Harvard Medical School; Dr. Irwin Redlener, president and co-founder of the Children's Health Fund; Diane Cornman-Levy, executive director, Federation of Neighborhood Centers; Sarah Martinez-Helfman, executive director of the Eagles Youth Partnership; and Dr. Robert Simmons , director of the Master of Public Health Program at the Jefferson School of Population Health.
“In 2011, GSK set out to understand how we can work more effectively in the communities where we live and serve patients, and to answer the question: ‘What can GSK do to be a better health partner?’” Connelly said in a statement. “As we embark on a new era of healthcare in the United States, we have an opportunity to build upon the national momentum not only to expand access to healthcare, but to develop innovative approaches, uncover new ideas, and rethink incentives for improving the health of the community as a whole.”
A link to the reply of the video of the main event can be found here.
wanna help the community? leave it alone.
you vaccines and big pharm drugs is killing the population and causing serious problems.— ubetterlisten
- Adolor
- Almac
- AmerisourceBergen
- AstraZeneca
- Auxilium
- Bayer
- Celgene
- Cephalon
- Endo
- GlaxoSmithKline
- Johnson & Johnson
- Kensey Nash
- Lannett
- Merck
- Pfizer
- Roche
- Sanofi-aventis
- Shire
- Stryker
- Synthes
- Teva
- ViroPharma
- West
- Centers for Disease Control and Prevention
- Centers for Medicare and Medicaid
- Clinical Trials
- Food and Drug Administration
- Office of Inspector General, Health and Human Services
- OIG Most-wanted list of fugitives
- Securities and Exchange Commission/Edgar filings
- U.S. Attorney's Office/Eastern Pennsylvania, health-care fraud
- U.S. Department of Health and Human Services
- BIO
- Jersey Association of Medical Equipment Services
- Pennsylvania Association of Medical Suppliers
- Pharmaceutical Research and Manufacturers of America
- Science Center
- American Health Lawyers Association
- Drug and Device Law
- Orange Book blog
- Taxpayers Against Fraud
- Bio Century
- Bio Space
- Cafe Pharma
- Financial Times
- In The Pipeline
- Monday Morning
- New York Times/Prescriptions
- Pharma Live
- Pharma Marketing
- Pharmalot
- The Placebo Effect
- Wall Street Journal/Health blog
